glp 1 and List of approved pending GLP-1 medications The Impact of GLP-1 Receptor

Sikirica M, Martin A, Wood R, Leith A, Piercy J, Higgins V

2017;26(4):620-632.e626

My name is RIta and as I approached my 71st birthday, I knew I needed to make a change

Those who continued the medication lost an additional 5.5%, meaning the difference between continuing and stopping was nearly 20 percentage points

In an email sent to BioSpace , a Novo representative said that the trials are ongoing but declined to comment further for this article

While incorporating various research designs provided a broad overview, it also introduced diversity in study methodologies, patient demographics, and data collecting methods